Atlas Trials

Study on Antiviral Therapy for HBeAg-positive Chronic Hepatitis B Patients Aged 1-16 Years

Clinical trial NCT04565262 · UNKNOWN

Trial details

NCT number
NCT04565262
Sponsor
Beijing 302 Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
HBeAg Positive Chronic Hepatitis B
Start date
2020-09-01
Primary completion
2023-07-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.